Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA (VISTN) · publisert 2021-10-29 12:39 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Pactum AS nærstående | – | disposal | 3 519 733 | 19,5 NOK | 2021-10-29 | NO0010734122 | XOSL - Oslo Børs | llm |
| Pactum Vekst AS nærstående | – | acquisition | 3 519 733 | 19,5 NOK | 2021-10-29 | NO0010734122 | XOSL - Oslo Børs | llm |
Vedlegg
- Skjema for melding om transaksjoner utfort av primaerinnsidere KRT-1500_kjop Pactum Vekst.pdf (tekst hentet ut)
- Skjema for melding om transaksjoner utfort av primaerinnsidere KRT-1500_salg Pactum.pdf (tekst hentet ut)
Meldingstekst
Pactum AS, a closely related party to the primary insider and board member Espen
W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares
in Vistin Pharma ASA at NOK 19.50 per share to its wholly-owned subsidiary
Pactum Vekst AS in connection with an internal reorganization of Pactum AS.
Pactum Vekst AS is also a closely related party to the primary insider and board
member Espen W. Marcussen in Vistin Pharma ASA.
Please refer to the attached notifications of trading for further details.